Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...
Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...
Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency affecting ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
VIRGINIA BEACH, Va. — A Virginia Beach man collapsed at home, was paralyzed and put on life support after contracting a rare neurological disorder that nearly killed him. Now Ra-Jon James is walking ...
Ali Sudderth, a 33-year-old woman said that she woke up with "tingly" toes and slowly her entire body became numb and she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results